Viehbacher Exits Sanofi
Christopher A. Viehbacher resigned as director of Sanofi immediately after its Board of Directors unanimously agreed to remove him as the company’s CEO yesterday. Chairman Serge Weinberg will replace...
View ArticleIsrael Set for “Modest” Pharma Growth
Israel’s pharmaceutical market value will increase from approximately $1.9 billion in 2013 to $2.34 billion, a compound annual growth rate of 2.8%, by 2020, says UK research and consulting firm...
View ArticleJ&J Strengthens Infectious Disease Pipeline with Alios Acquisition
Johnson & Johnson completed the acquisition of Alios BioPharma, a privately held clinical-stage biopharmaceutical company focused on developing therapies for viral diseases, for a total purchase...
View ArticleEMA States Position on Confidential Information
In response to a letter the European Medicines Agency received from the European Ombudsman on Oct. 27, 2014, the agency is clarifying its policy on commercially confidential information. EMA states in...
View ArticleActavis Marches Ahead with Acquisition Spree
Actavis’s agreed purchase of Allergan for around $66 billion will help grow the Dublin-based specialty pharma firm to a $22 billion healthcare company in 2015 — a “dramatic elevation”, given the $8.7...
View ArticlePharma Showing Signs of Stability Despite Patent Cliffs
The pharmaceutical market is beginning to show signs of stability, with a review of 30 leading companies highlighting combined revenues of $718.7 billion in 2013, down just 0.2% from 2012, according to...
View ArticleEMA Revises Conflict-of-Interest Policy
The European Medicines Agency (EMA) has published its revised policy on handling declarations of interests for scientific-committee members and experts. The revisions strive for a more balanced...
View ArticleShire to Relocate More Than 500 Jobs to Lexington, MA
Shire plans to relocate more than 500 positions to Massachusetts from its Chesterbrook, PA, site and establish Lexington, MA, as the company’s US operational headquarters. The transition is a...
View ArticleBiotech Professionals and Drug Manufacturers Targeted by Latest Cyber Threat
By Randi Hernandez. The New York Times (NYT) reported on Dec. 1, 2014 that companies in the biotechnology sector might be the latest victims of computer security breaches. The perpetrators, who are...
View ArticleClik here to view.
Indonesia “Most Promising” Emerging Market in 2015
Indonesia is expected to be the most promising market for pharma next year, thanks to its new healthcare insurance scheme Jaminan Kesehatan Nasional (JKN), according to Reenita Das, partner and senior...
View Article
